Description
The Rapid SARS-CoV-2 Antigen Test Card is a lateral flow immunoassay intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2.
The Boson BioTech COVID-19 Antigen Home Test detects SARS-CoV-2 virus antigen in anterior nasal swabs quickly and qualitatively. Each pack has two individual tests with results in 15 minutes.
The Rapid SARS-CoV-2 Antigen Test Card is a lateral flow immunoassay intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2.
This product has not been FDA cleared or approved, but has been authorized by FDA under an EUA; This product has been authorized only for the detection of proteins from SARS- CoV-2, not for any other viruses or pathogens; and, the emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.
Weight | 0.31 lbs |
---|---|
Dimensions | 6.1 × 2.4 × 1.26 in |
Only logged in customers who have purchased this product may leave a review.
The Boson BioTech COVID-19 Antigen Home Test detects SARS-CoV-2 virus antigen in anterior nasal swabs quickly and qualitatively. Each pack has two individual tests with results in 15 minutes.
The Rapid SARS-CoV-2 Antigen Test Card is a lateral flow immunoassay intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2.
This product has not been FDA cleared or approved, but has been authorized by FDA under an EUA; This product has been authorized only for the detection of proteins from SARS- CoV-2, not for any other viruses or pathogens; and, the emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.
Weight | 0.31 lbs |
---|---|
Dimensions | 6.1 × 2.4 × 1.26 in |
There are no reviews yet.
Only logged in customers who have purchased this product may leave a review.
©2023 360 HEALTH SERVICES | All Rights Reserved.
Reviews
There are no reviews yet.